CA2 and neoplasm: In light of recent findings that SOCE promotes carcinogenesis and proposals to use inhibitors of SOCE for anticancer therapy, our findings demonstrate that drugs inhibiting the Ca2+ channels that mediate SOCE would compromise antitumour immunity and promote tumour growth.